These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 23539110)

  • 21. Adolescents and Young Adults With Sickle Cell Disease: Nociplastic Pain and Pain Catastrophizing as Predictors of Pain Interference and Opioid Consumption.
    Kuisell C; Ploutz-Snyder R; Williams DA; Voepel-Lewis T; Hutchinson RJ; Dudding KM; Bridges C; Lavoie Smith EM
    Clin J Pain; 2023 Jul; 39(7):326-333. PubMed ID: 37083638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30-day readmission rate.
    Frei-Jones MJ; Field JJ; DeBaun MR
    Pediatr Blood Cancer; 2009 Sep; 53(3):401-5. PubMed ID: 19422031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using the consolidated framework for implementation research to identify recruitment barriers and targeted strategies for a shared decision-making randomized clinical trial in pediatric sickle cell disease.
    Strong H; Hood AM; Johnson Y; Hackworth R; Reed-Shackelford M; Ramaswamy R; Varughese T; Quinn CT; Crosby LE
    Clin Trials; 2023 Jun; 20(3):211-222. PubMed ID: 36794731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ASPMN Position Statement: Authorized Agent Controlled Analgesia.
    Czarnecki M; Cooney MF; Wuhrman E
    Pain Manag Nurs; 2024 Jun; 25(3):209-210. PubMed ID: 38653642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ketamine for Sickle Cell Vaso-Occlusive Crises: A Systematic Review.
    Alshahrani MS; Alghamdi MA
    Saudi J Med Med Sci; 2021; 9(1):3-9. PubMed ID: 33519337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-world implementation of the David-Carroll buprenorphine protocol for pain management in sickle cell disease.
    Torres C; Galadanci N; Osborn J; Kanter J
    Am J Hematol; 2024 Sep; 99(9):1834-1836. PubMed ID: 38895887
    [No Abstract]   [Full Text] [Related]  

  • 27. Mental health, pain and likelihood of opioid misuse among adults with sickle cell disease.
    Jonassaint CR; Parchuri E; O'Brien JA; Lalama CM; Lin J; Badawy SM; Hamm ME; Stinson J; Lalloo C; Carroll CP; Saraf SL; Gordeuk VR; Cronin R; Shah N; Lanzkron SM; Liles D; Trimnell C; Bailey L; Lawrence RH; Abebe KZ
    Br J Haematol; 2024 Mar; 204(3):1029-1038. PubMed ID: 38171495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developing an Implementation Blueprint for the NIH HEAL Initiative GRACE Trial: Perspectives on Acupuncture and Guided Relaxation for Chronic Sickle Cell Disease Pain.
    Knisely MR; Rivera E; deMartelly VA; Abdulkadir A; Doorenbos AZ; Ezenwa MO; Molokie RE; Li H; Shah N; Schlaeger JM; Patil CL
    J Integr Complement Med; 2023 Oct; 29(10):683-688. PubMed ID: 37184905
    [No Abstract]   [Full Text] [Related]  

  • 29. Biopsychosocial Factors Associated With Pain and Pain-Related Outcomes in Adults and Children With Sickle Cell Disease: A Multivariable Analysis of the GRNDaD Multicenter Registry.
    Kenney MO; Wilson S; Shah N; Bortsov A; Smith WR; Little J; Lanzkron S; Kanter J; Padrino S; Owusu-Ansah A; Cohen A; Desai P; Manwani D; Rehman SSU; Hagar W; Keefe F
    J Pain; 2024 Jan; 25(1):153-164. PubMed ID: 37544393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective review of acupuncture use for the treatment of pain in sickle cell disease patients: descriptive analysis from a single institution.
    Lu K; Cheng MC; Ge X; Berger A; Xu D; Kato GJ; Minniti CP
    Clin J Pain; 2014 Sep; 30(9):825-30. PubMed ID: 24322996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of health-related quality of life among adults hospitalized with sickle cell disease vaso-occlusive crisis.
    Esham KS; Rodday AM; Smith HP; Noubary F; Weidner RA; Buchsbaum RJ; Parsons SK
    Blood Adv; 2020 Jan; 4(1):19-27. PubMed ID: 31891655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Daily Opioid Use Fluctuates as a Function of Pain, Catastrophizing, and Affect in Patients With Sickle Cell Disease: An Electronic Daily Diary Analysis.
    Finan PH; Carroll CP; Moscou-Jackson G; Martel MO; Campbell CM; Pressman A; Smyth JM; Tremblay JM; Lanzkron SM; Haythornthwaite JA
    J Pain; 2018 Jan; 19(1):46-56. PubMed ID: 28943232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting pain at its source in sickle cell disease.
    Gupta K; Jahagirdar O; Gupta K
    Am J Physiol Regul Integr Comp Physiol; 2018 Jul; 315(1):R104-R112. PubMed ID: 29590553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Communicating and understanding pain: Limitations of pain scales for patients with sickle cell disorder and other painful conditions.
    Collins PJ; Renedo A; Marston CA
    J Health Psychol; 2022 Jan; 27(1):103-118. PubMed ID: 32744117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous Ambulatory Delivery Device Use for Patients Managed by an Inpatient Palliative Care Team.
    Peters M; Kutzko DJ; Stilos K
    Pain Manag Nurs; 2024 Jun; 25(3):e236-e242. PubMed ID: 38616457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attitudes and Beliefs of Nurses and Nurse Assistants toward Patients with Sickle Cell Disease: A Mixed Methods Study.
    Reich J; Cantrell MA; Smeltzer SC
    Pain Manag Nurs; 2024 Apr; 25(2):122-130. PubMed ID: 37865561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using virtual multiteam systems to conduct a multisite randomized clinical trial in the part C early intervention system: Benefits, challenges, and lessons learned.
    Ingersoll B; Espinel A; Nauman J; Broder-Fingert S; Carter AS; Sheldrick RC; Stone WL; Wainer AL
    Contemp Clin Trials; 2024 Aug; 143():107585. PubMed ID: 38821261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain network hypersensitivity underlies pain crises in sickle cell disease.
    Joo P; Kim M; Kish B; Nair VV; Tong Y; Liu Z; O'Brien ARW; Harte SE; Harris RE; Lee U; Wang Y
    Sci Rep; 2024 Mar; 14(1):7315. PubMed ID: 38538687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcutaneous Patient-Controlled Analgesia in Home-Based Palliative Care: "
    Julião M; Calaveiras P; Bruera E; de Sousa PF
    J Pain Palliat Care Pharmacother; 2024 Jun; 38(2):143-148. PubMed ID: 38407922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precision, integrative medicine for pain management in sickle cell disease.
    Smith WR; Valrie CR; Jaja C; Kenney MO
    Front Pain Res (Lausanne); 2023; 4():1279361. PubMed ID: 38028431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.